Evidence map›Paper›PMID 34935640›Full record

ArticleJCI insight2021

A population-level strain genotyping method to study pathogen strain dynamics in human infections.

Sarah J Morgan, Samantha L Durfey, Sumedha Ravishankar, Peter Jorth, Wendy Ni, Duncan T Skerrett, Moira L Aitken, Edward F McKone, Stephen J Salipante, Matthew C Radey and 1 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Sarah J MorganDepartment of Microbiology, University of Washington School of Medicine, Seattle, Washington, USA.
Samantha L DurfeyDepartment of Microbiology, University of Washington School of Medicine, Seattle, Washington, USA.
Sumedha RavishankarDepartment of Microbiology, University of Washington School of Medicine, Seattle, Washington, USA.
Peter JorthDepartment of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Wendy NiDepartment of Microbiology, University of Washington School of Medicine, Seattle, Washington, USA.
Duncan T SkerrettDepartment of Microbiology, University of Washington School of Medicine, Seattle, Washington, USA.
Moira L AitkenDepartment of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
Edward F McKoneSt. Vincent's University Hospital, Dublin, Ireland.
Stephen J SalipanteDepartment of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA.
Matthew C RadeyDepartment of Microbiology, University of Washington School of Medicine, Seattle, Washington, USA.
Pradeep K SinghDepartment of Microbiology, University of Washington School of Medicine, Seattle, Washington, USA.
University of Washington · USCedars-Sinai Medical Center · USSt. Vincent's University Hospital · IE

Funding

Translational Research Center to Expedite Novel Therapies in Cystic FibrosisP30DK089507 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI Christopher Hooper Goss, Lucas R Hoffman · 2010 to 2026
$21.4M
Field Study to Understand Progression of Chronic Airway InfectionR01HL148274 · NHLBI · UNIVERSITY OF WASHINGTON · PI EMOND, MARY J, SINGH, PRADEEP K · 2019 to 2022
$2.9M
Studies on bacterial populations and therapeutics for CF lung infectionsK24HL102246 · NHLBI · UNIVERSITY OF WASHINGTON · PI SINGH, PRADEEP K · 2010 to 2019
$1.6M
Clinical Effects of Evolved Variation in Infecting Bacterial PopulationsR56HL141098 · NHLBI · UNIVERSITY OF WASHINGTON · PI EMOND, MARY J, SINGH, PRADEEP K · 2018 to 2018
$674k
NHLBI NIH HHS K24 HL102246NHLBI NIH HHS R01 HL148274NHLBI NIH HHS R56 HL141098NIDDK NIH HHS P30 DK089507
6 · The paper itself

Abstract

A hallmark of chronic bacterial infections is the long-term persistence of 1 or more pathogen species at the compromised site. Repeated detection of the same bacterial species can suggest that a single strain or lineage is continually present. However, infection with multiple strains of a given species, strain acquisition and loss, and changes in strain relative abundance can occur. Detecting strain-level changes and their effects on disease is challenging because most methods require labor-intensive isolate-by-isolate analyses, and thus, only a few cells from large infecting populations can be examined. Here, we present a population-level method for enumerating and measuring the relative abundance of strains called population multi-locus sequence typing (PopMLST). The method exploits PCR amplification of strain-identifying polymorphic loci, next-generation sequencing to measure allelic variants, and informatic methods to determine whether variants arise from sequencing errors or low-abundance strains. These features enable PopMLST to simultaneously interrogate hundreds of bacterial cells that are cultured en masse from patient samples or are present in DNA directly extracted from clinical specimens without ex vivo culture. This method could be used to detect epidemic or super-infecting strains, facilitate understanding of strain dynamics during chronic infections, and enable studies that link strain changes to clinical outcomes.

Indexed as

Disease Transmission, InfectiousGenotyping TechniquesHumansInfectionsBacterial infectionsInfectious diseaseMicrobiologyMolecular genetics

Identifiers

PMID34935640
PMCPMC8783678
OpenAlexW4226354984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.